BioTie Therapies Oyj | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
16,441.00
17,672.00
11,058.00
35,603.00
223,359.00
Depreciation, Depletion & Amortization
6,999.00
8,473.00
15,012.00
21,582.00
23,234.00
Other Funds
91.00
-
194.00
56.00
50,787.00
Funds from Operations
60,402.00
79,196.00
63,975.00
20,118.00
123,663.00
Changes in Working Capital
21,220.00
4,247.00
20,294.00
9,531.00
26,906.00
Net Operating Cash Flow
39,182.00
74,949.00
43,681.00
29,649.00
96,757.00
Capital Expenditures
7,164.00
7,783.00
7,066.00
7,085.00
14,376.00
Sale of Fixed Assets & Businesses
-
-
-
-
6,385.00
Purchase/Sale of Investments
30,429.00
190,109.00
78,170.00
199,751.00
-
Net Investing Cash Flow
45,092.00
293,825.00
85,236.00
101,732.00
7,991.00
Issuance/Reduction of Debt, Net
909.00
336,922.00
875.00
1,587.00
2,409.00
Net Financing Cash Flow
11,968.00
352,937.00
17,415.00
73,877.00
58,797.00
Net Change in Cash
6,058.00
134,062.00
24,140.00
365.00
148,788.00
Free Cash Flow
35,139.00
69,865.00
37,760.00
23,457.00
83,069.00
Deferred Taxes & Investment Tax Credit
9,520.00
6,681.00
3,975.00
11,190.00
54,044.00
Net Assets from Acquisitions
7,499.00
476,151.00
-
294,400.00
-
Change in Capital Stock
12,786.00
16,015.00
18,096.00
75,520.00
10,419.00
Exchange Rate Effect
-
1.00
-
2,159.00
1,225.00
About BioTie Therapies Oyj
View Profile
